NZTE names health technology finalists for US

Ten finalists head for a market readiness programme before taking on the US

NZTE has selected ten companies as finalists in its Focus on Health Challenge business development competition.

The finalists range from software to medical devices and wound care therapies, and include virtual reality training systems, hospital management software, anticoagulant management and monitoring, a wound care tissue supplement, a bacterial water checking device and an asthma support programme.

NZTE's operations group director, Hans Frauenlob, says that the competition is all about fast-tracking New Zealand innovations into the United States health industry. “Time and time again we see New Zealand companies head to the United States, and many of them simply don’t make the kind traction they hoped for. The US is a large, and difficult market - the health sector particularly so with many layers of rules and regulations to get through,” Mr Frauenlob says. Frauenlob says all the finalists have robust business plans and management teams in place, and their products and services have strong potential in the US. The finalists are: · B2P Micro-Bioinformatics Technology from B2P Testing — bacterial water and food testing technology · CapPlan from Emendo — capacity and operational management software solution · Endoform Infection Control from Mesynthes Ltd — wound care and soft tissue reconstruction supplement · Engineering Assisted Surgery Limited, a team entry — MRI scanning and implant solution · Flexible Bronchoscopy Simulator from Airway Ltd — virtual reality air ways simulator · GASP from Comprehensive Health — Asthma support programme · Low cost, multiplex immunodiagnostic test platform from Pictor Ltd — immunodiagnostic testing platform · SIMTICS Healthcare from Go Virtual Medical Ltd — e-learning with virtual reality simulator · The Future of Warfarin Management from INR Online Ltd — web based anticoagulant management system · Volpara Quantitative Breast Screening from Matakina — computer aided detection tools for x-ray screening.  More than 100 entries were received, from which 20 semi-finalists were selected to pitch their products to an international panel of judges. Over the next six months the 10 finalists will participate in a "market readiness" programme to help finalists prepare for presenting to potential buyers, customers, investors and partners in the US next year.

Join the newsletter!

Error: Please check your email address.

Tags Development ID

Show Comments
[]